Multiple, Sequential Light, Laser Sources No Benefit in Rosacea

This article originally appeared here.
Share this content:
Multiple, Sequential Light, Laser Sources No Benefit in Rosacea
Multiple, Sequential Light, Laser Sources No Benefit in Rosacea

MONDAY, July 18, 2016 (HealthDay News) -- Use of multiple, sequential light and laser sources to activate aminolevulinic acid (ALA) in photodynamic therapy (PDT) does not lead to statistically significant improvements in patient outcome for rosacea, according to a study published online July 4 in the Journal of Cosmetic Dermatology.

Daniel P. Friedmann, M.D., from Westlake Dermatology & Cosmetic Surgery in Austin, Texas, and colleagues examined ALA-PDT for rosacea using blue light sequentially with red light, pulsed-dye laser (PDL), and/or intense pulsed light (IPL) in a retrospective study involving 39 patients. Treatment groups were: blue light + PDL; blue light + IPL; blue light + PDL + IPL; and blue light + red light + PDL + IPL. A telephone questionnaire was used to obtain patient-reported outcome measures.

The researchers found that patient-reported rosacea and overall skin quality improvement were not significantly different between the groups. The only significant difference in post-procedure adverse events was decreased peeling following blue light + IPL compared with blue light + PDL (P = 0.041) and blue light + IPL + PDL (P = 0.005).

"The use of multiple, sequential light and laser sources with ALA-PDT for rosacea, while well tolerated, did not lead to statistically significant improvements in patient-reported efficacy," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Deaths, Cardiac Arrest Not Rare in Triathlon Participants

Deaths, Cardiac Arrest Not Rare in Triathlon Participants

Incidence of death or cardiac arrest 1.74 per 100,000 participants; higher incidence in men, with age

ACP Does Not Support Legalization of Assisted Suicide

ACP Does Not Support Legalization of Assisted Suicide

Legalization would affect trust in the patient-physician relationship, and in the medical profession

AAP: Epinephrine Admin Training Needed in Many Schools

AAP: Epinephrine Admin Training Needed in Many Schools

In 2015 to 2016, 2.7 percent reported that epinephrine was administered by unlicensed staff

is free, fast, and customized just for you!

Already a member?

Sign In Now »